About the project

 

V.A. Cure is a European MSCA-ITN network aiming to uncover core mechanisms of initiation and maintenance of Vascular Anomalies (VAs) and to leverage this information for establishing novel therapeutic strategies. The network consortium consists of 7 academic laboratories and 2 companies from across Europe, and is supported by 8 partner organisations (5 companies, one university, one hospital and a patient organization).

The 14 Early Stage Researchers (ESRs) will be a part of  the unique international PhD program, consisting of an individual research project, the network’s training programme, intersectoral secondments and outreach activities. Project goal is to  ensure a comprehensive perception of the research and drug/technology development in pharma industry/biotech and academia.

The individual research is a part of the V.A. Cure project, which is developed in four stages:

14 Early Stage Researchers to research the causes and mechanisms of aberrant vascular function   A comprehensive training programme provided by experts in vascular biology from across Europe   International cooperation on vascular anomalies research with participating organisations from across the whole chain

News

  • Embracing diversity

    Diversity and environment that fosters equal opportunities in research are very important aspects of our project. Through inclusion of diversity, we grow professionally and personally.Early stage researchers of V.A.Cure project are coming from all over the world: Singapore, Iran, Vietnam, Turkey, Italy, Germany, Slovenia, Lebanon, Austria, Spain and USA.

  • Gender balance in our research

    Equal participation of men and women in science is a topic of a high global importance. Thus, equal opportunities during selection process were important aspect of our project. Therefore, we are proud to announce that we have obtained gender equality in our team of 14 Early Stage Researchers.

  • Selected candidates

    We are very proud to announce the chosen candidates per each ESR position. ESR1-Martina de Bortoli, ESR 2- Murat Alpaslan, ESR3-Franziska Kohl, ESR4-Hans Schoofs, ESR5-Bojana Lazovic, ESR6-Antonio Queiro Palou, ESR7-Marle Kraft, ESR8-Mohammad Hassan Ansarizadeh, ESR9-Nastasja Grdseloff, ESR10- Cường Phạm Văn, ESR11- Joseph Lim Jing Heng, ESR12-Martina Rossi, ESR13-Tala Al Tabosh, ESR14- Hoang-Tuan Nguyen.

  • Selection process is finalized

    V.A.Cure project is happy to announce that selection process for 14 Early Stage Researchers is officially closed. Chosen candidates will start with their individual research in September and October 2019.More information on each research can be found on our research page.

V.A. Cure Retweeted ·
VASCERN
@vascern



The #VascularAnomalies WG wave goodbye to #VASCERNDays2019! 🤗👋 See you all next year! #ERNeu #RareDiseases #ShareCareCure #vascularmalformations #Boomerang @MiikkaVikkula @LaurenceBoon1 @leoschultzekool @HecovanNijmegen @LGDA_EU @HevasNederland @VASCAPA @pgasparella https://t.co/1s3V6IbUlE

View on Twitter

5

0

Follow us on Facebook

Project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 814316